Revance Therapeutics | 税前利润

Pre Tax Profit 更改 日
Eli Lilly USD 2.59B 2.27B 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pacira USD 48.15M 121K 2023-09
Supernus Pharmaceuticals USD 990K 38.1M 2023-12



Revance Therapeutics 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.